Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sökresultat